documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
89 rows where docket_id = "FDA-2010-N-0002" and posted_year = 2010 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_month, comment_start_date, open_for_comment, posted_date (date), comment_start_date (date), last_modified (date)
document_type 4
- Rule 44
- Supporting & Related Material 31
- Notice 11
- Other 3
posted_year 1
- 2010 · 89 ✖
agency_id 1
- FDA 89
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2010-N-0002-0088 | FDA | None FDA-2010-N-0002 | New Animal Drugs: Deslorelin | Rule | NFR-Notice of Final Rule | 2010-12-28T05:00:00Z | 2010 | 12 | 2010-12-28T05:00:00Z | 2010-12-28T15:43:43Z | 2010-32554 | 0 | 0 | 0900006480bc0c09 | |
| FDA-2010-N-0002-0089 | FDA | None FDA-2010-N-0002 | Freedom of Information Summary - [NADA-141-319] - Deslorelin acetate Injection Horses/Estrous mares | Other | FOIS-Freedom of Information Summary (No Federal Register Publication) | 2010-12-28T05:00:00Z | 2010 | 12 | 2010-12-28T05:00:00Z | 2010-12-28T16:01:31Z | 0 | 0 | 0900006480bc13dc | ||
| FDA-2010-N-0002-0087 | FDA | None FDA-2010-N-0002 | New Animal Drugs; Change of Sponsor's Address | Rule | NFR-Notice of Final Rule | 2010-12-21T05:00:00Z | 2010 | 12 | 2010-12-21T05:00:00Z | 2010-12-21T14:31:22Z | 2010-31952 | 0 | 0 | 0900006480bbcc1e | |
| FDA-2010-N-0002-0085 | FDA | None FDA-2010-N-0002 | New Animal Drugs: Mupirocin | Rule | NFR-Notice of Final Rule | 2010-12-20T05:00:00Z | 2010 | 12 | 2010-12-20T05:00:00Z | 2010-12-20T14:51:05Z | 2010-31870 | 0 | 0 | 0900006480bba052 | |
| FDA-2010-N-0002-0086 | FDA | None FDA-2010-N-0002 | Freedom of Information Summary - [ANADA-200-457] | Supporting & Related Material | FOIS-Freedom of Information Summary | 2010-12-20T05:00:00Z | 2010 | 12 | 2010-12-20T15:04:13Z | 0 | 0 | 0900006480bba73b | |||
| FDA-2010-N-0002-0082 | FDA | None FDA-2010-N-0002 | Freedom of Information Summary [ANADA 200-473 Pharmasin Soluble (tylosin tartrate)] | Supporting & Related Material | FOIS-Freedom of Information Summary | 2010-12-08T05:00:00Z | 2010 | 12 | 2010-12-08T15:55:03Z | 0 | 0 | 0900006480bb1b46 | |||
| FDA-2010-N-0002-0081 | FDA | None FDA-2010-N-0002 | Oral Dosage Form New Animal Drugs: Tylosin | Rule | NFR-Notice of Final Rule | 2010-12-08T05:00:00Z | 2010 | 12 | 2010-12-08T05:00:00Z | 2010-12-08T15:43:21Z | 2010-30814 | 0 | 0 | 0900006480bb1e23 | |
| FDA-2010-N-0002-0084 | FDA | None FDA-2010-N-0002 | Freedom of Information Summary [ANADA 200-061- FLU-NIX (flunixin meglumine) Injectable Solution)] | Supporting & Related Material | FOIS-Freedom of Information Summary | 2010-12-08T05:00:00Z | 2010 | 12 | 2010-12-08T16:26:07Z | 0 | 0 | 0900006480bb1b67 | |||
| FDA-2010-N-0002-0083 | FDA | None FDA-2010-N-0002 | Implantation or Injectable Dosage Form New Animal Drugs: Flunixin | Rule | NFR-Notice of Final Rule | 2010-12-08T05:00:00Z | 2010 | 12 | 2010-12-08T05:00:00Z | 2010-12-08T16:18:02Z | 2010-30769 | 0 | 0 | 0900006480bb1ea7 | |
| FDA-2010-N-0002-0080 | FDA | None FDA-2010-N-0002 | New Animal Drugs: Change of Sponsor's Name and Address | Rule | NFR-Notice of Final Rule | 2010-11-26T05:00:00Z | 2010 | 11 | 2010-11-26T05:00:00Z | 2024-11-07T22:30:37Z | 2010-29693 | 1 | 0 | 0900006480ba43cf | |
| FDA-2010-N-0002-0079 | FDA | None FDA-2010-N-0002 | Intramammary Dosage Form New Animal Drugs: Cloxacillin Benzathine | Rule | NFR-Notice of Final Rule | 2010-11-22T05:00:00Z | 2010 | 11 | 2010-11-22T05:00:00Z | 2024-11-07T22:25:26Z | 2010-29326 | 1 | 0 | 0900006480ba0922 | |
| FDA-2010-N-0002-0078 | FDA | None FDA-2010-N-0002 | New Animal Drugs; Change of Sponsor: Sulfadiazine and Pyrimethamine Suspension | Rule | NFR-Notice of Final Rule | 2010-11-15T05:00:00Z | 2010 | 11 | 2010-11-15T17:45:37Z | 2010-28549 | 0 | 0 | 0900006480b88cdb | ||
| FDA-2010-N-0002-0077 | FDA | None FDA-2010-N-0002 | New Animal Drugs; Change of Sponsors Name | Rule | CEP-Certificate Extending Patent Term | 2010-11-10T05:00:00Z | 2010 | 11 | 2010-11-10T05:00:00Z | 2010-11-10T15:57:56Z | 2010-28307 | 0 | 0 | 0900006480b86258 | |
| FDA-2010-N-0002-0075 | FDA | None FDA-2010-N-0002 | Oral Dosage Form New Animal Drugs: Domperidone | Rule | NFR-Notice of Final Rule | 2010-11-01T04:00:00Z | 2010 | 11 | 2010-11-01T15:15:29Z | 2010-27524 | 0 | 0 | 0900006480b7c883 | ||
| FDA-2010-N-0002-0076 | FDA | None FDA-2010-N-0002 | Freedom of Information Summary - EQUIDONE Gel [NADA-141-314] Domperidone | Supporting & Related Material | FOIS-Freedom of Information Summary | 2010-11-01T04:00:00Z | 2010 | 11 | 2010-11-01T16:05:49Z | 0 | 0 | 0900006480b7d0ab | |||
| FDA-2010-N-0002-0074 | FDA | None FDA-2010-N-0002 | New Animal Drugs: Change of Sponsor; Monensin Blocks | Rule | NFR-Notice of Final Rule | 2010-10-28T04:00:00Z | 2010 | 10 | 2010-10-28T15:36:14Z | 2010-27287 | 0 | 0 | 0900006480b79676 | ||
| FDA-2010-N-0002-0073 | FDA | None FDA-2010-N-0002 | Animal Drugs, Feeds, and Related Products; Withdrawals of Approvals of New Animal Drug Applications: Aklomide; Levamisole Hydrochloride; Nitromide and Sulfanitran | Rule | NFR-Notice of Final Rule | 2010-10-26T04:00:00Z | 2010 | 10 | 2010-10-26T14:48:15Z | 2010-27011 | 0 | 0 | 0900006480b7753a | ||
| FDA-2010-N-0002-0071 | FDA | None FDA-2010-N-0002 | Certain Other Dosage Form New Animal Drugs: Progesterone Intravaginal Inserts | Rule | NFR-Notice of Final Rule | 2010-10-14T04:00:00Z | 2010 | 10 | 2010-10-14T17:22:27Z | 2010-25893 | 0 | 0 | 0900006480b6eed0 | ||
| FDA-2010-N-0002-0072 | FDA | None FDA-2010-N-0002 | Progesterone NADA 141-200 - Freedom of Information Summary | Supporting & Related Material | FOIS-Freedom of Information Summary | 2010-10-14T04:00:00Z | 2010 | 10 | 2010-10-14T17:39:37Z | 0 | 0 | 0900006480b6f3b2 | |||
| FDA-2010-N-0002-0070 | FDA | None FDA-2010-N-0002 | Implantation or Injectable Dosage Form New Animal Drugs; Ceftiofur Crystalline Free Acid | Other | FOIS-Freedom of Information Summary (No Federal Register Publication) | 2010-10-12T04:00:00Z | 2010 | 10 | 2010-10-12T04:00:00Z | 2010-10-12T15:38:15Z | 0 | 0 | 0900006480b6d1c7 | ||
| FDA-2010-N-0002-0069 | FDA | None FDA-2010-N-0002 | Implantation and Injectable Dosage Form New Animal Drugs: Ceftiofur Crystalline Free Acid; Technical Amendment | Rule | NFR-Notice of Final Rule | 2010-10-12T04:00:00Z | 2010 | 10 | 2010-10-12T04:00:00Z | 2010-10-12T15:25:22Z | 2010-25527 | 0 | 0 | 0900006480b6c491 | |
| FDA-2010-N-0002-0066 | FDA | None FDA-2010-N-0002 | Implantation or Injectable Dosage Form New Animal Drugs; Dexmedetomidine | Rule | NFR-Notice of Final Rule | 2010-09-30T04:00:00Z | 2010 | 9 | 2010-09-30T04:00:00Z | 2010-09-30T15:28:17Z | 2010-24494 | 0 | 0 | 0900006480b64109 | |
| FDA-2010-N-0002-0067 | FDA | None FDA-2010-N-0002 | Freedom of Information Summary [NADA 141-267 Dexdomitor (dexmedetomidine hydrochloride) sterile injectable solution cats] | Supporting & Related Material | FOIS-Freedom of Information Summary | 2010-09-30T04:00:00Z | 2010 | 9 | 2010-09-30T15:37:30Z | 0 | 0 | 0900006480b64614 | |||
| FDA-2010-N-0002-0068 | FDA | None FDA-2010-N-0002 | New Animal Drugs for Use in Animal Feeds; Melengestrol | Rule | NFR-Notice of Final Rule | 2010-09-30T04:00:00Z | 2010 | 9 | 2010-09-30T04:00:00Z | 2010-09-30T15:42:59Z | 2010-24480 | 0 | 0 | 0900006480b64158 | |
| FDA-2010-N-0002-0064 | FDA | None FDA-2010-N-0002 | Implantation and Injectable Dosage Form New Animal Drugs: Firocoxib | Rule | NFR-Notice of Final Rule | 2010-09-28T04:00:00Z | 2010 | 9 | 2010-09-28T04:00:00Z | 2010-09-28T14:58:35Z | 2010-24254 | 0 | 0 | 0900006480b62263 | |
| FDA-2010-N-0002-0065 | FDA | None FDA-2010-N-0002 | Freedom of Information Summary - EQUIOXX Injection [NADA-141-313] Firocoxib | Supporting & Related Material | FOIS-Freedom of Information Summary | 2010-09-28T04:00:00Z | 2010 | 9 | 2010-09-28T16:22:04Z | 0 | 0 | 0900006480b620ce | |||
| FDA-2010-N-0002-0063 | FDA | None FDA-2010-N-0002 | Animal Drugs, Feeds, and Related Products; Withdrawals of Approvals of New Animal Drug Applications: Chloramphenicol; Lincomycin;Pyrantel Tartrate; and Tylosin Phosphate and Sulfamethazine | Rule | NFR-Notice of Final Rule | 2010-09-14T04:00:00Z | 2010 | 9 | 2010-09-14T15:22:40Z | 2010-22808 | 0 | 0 | 0900006480b4ea9e | ||
| FDA-2010-N-0002-0062 | FDA | None FDA-2010-N-0002 | Ophthalmic and Topical Dosage Form New Animal Drugs: Gentamicin and Betamethasone Ophthalmic Solution; Technical Amendment | Rule | NFR-Notice of Final Rule | 2010-09-08T04:00:00Z | 2010 | 9 | 2010-09-08T04:00:00Z | 2010-09-09T15:50:59Z | 2010-22276 | 0 | 0 | 0900006480b48200 | |
| FDA-2010-N-0002-0061 | FDA | None FDA-2010-N-0002 | Oral Dosage Form New Animal Drugs: Tiamulin | Rule | NFR-Notice of Final Rule | 2010-09-08T04:00:00Z | 2010 | 9 | 2010-09-08T04:00:00Z | 2010-09-09T16:00:35Z | 2010-22277 | 0 | 0 | 0900006480b481aa | |
| FDA-2010-N-0002-0059 | FDA | None FDA-2010-N-0002 | New Animal Drugs for Use in Animal Feed: Ractopamine | Notice | NFR-Notice of Final Rule | 2010-09-03T04:00:00Z | 2010 | 9 | 2010-09-03T04:00:00Z | 2010-09-03T15:18:04Z | 0 | 0 | 0900006480b44db9 | ||
| FDA-2010-N-0002-0056 | FDA | None FDA-2010-N-0002 | New Animal Drugs: Change of Sponsor's Name and Address | Rule | NFR-Notice of Final Rule | 2010-09-03T04:00:00Z | 2010 | 9 | 2010-09-03T04:00:00Z | 2010-09-03T14:51:56Z | 2010-22044 | 0 | 0 | 0900006480b4490f | |
| FDA-2010-N-0002-0060 | FDA | None FDA-2010-N-0002 | Freedom of Information - [NADA 141-225] - Optaflexx plus Rumensin plus Tylan | Supporting & Related Material | FOIS-Freedom of Information Summary | 2010-09-03T04:00:00Z | 2010 | 9 | 2010-09-03T15:21:33Z | 0 | 0 | 0900006480b44dbc | |||
| FDA-2010-N-0002-0055 | FDA | None FDA-2010-N-0002 | Freedom of Information - [NADA 141-229] - Resflor Gold | Supporting & Related Material | FOIS-Freedom of Information Summary | 2010-09-03T04:00:00Z | 2010 | 9 | 2010-09-03T14:48:53Z | 0 | 0 | 0900006480b44d3d | |||
| FDA-2010-N-0002-0057 | FDA | None FDA-2010-N-0002 | New Animal Drugs; Change of Sponsor: Penicillin G Benzathine and Penicillin G Procaine Suspension; Penicillin G Procaine Aqueous Suspension | Rule | NFR-Notice of Final Rule | 2010-09-03T04:00:00Z | 2010 | 9 | 2010-09-03T04:00:00Z | 2010-09-03T15:04:07Z | 2010-22042 | 0 | 0 | 0900006480b449d2 | |
| FDA-2010-N-0002-0053 | FDA | None FDA-2010-N-0002 | Freedom of Information - [NADA 141-224] - Optaflexx plus Rumensin plus Tylan | Supporting & Related Material | FOIS-Freedom of Information Summary | 2010-09-03T04:00:00Z | 2010 | 9 | 2010-09-03T14:41:24Z | 0 | 0 | 0900006480b44d38 | |||
| FDA-2010-N-0002-0052 | FDA | None FDA-2010-N-0002 | New Animal Drugs for Use in Animal Feed: Ractopamine | Rule | NFR-Notice of Final Rule | 2010-09-03T04:00:00Z | 2010 | 9 | 2010-09-03T04:00:00Z | 2010-09-03T14:36:56Z | 2010-22071 | 0 | 0 | 0900006480b444d4 | |
| FDA-2010-N-0002-0054 | FDA | None FDA-2010-N-0002 | Implantation or Injectable Dosage Form New Animal Drugs: Florfenicol and Flunixin | Rule | NFR-Notice of Final Rule | 2010-09-03T04:00:00Z | 2010 | 9 | 2010-09-03T14:45:33Z | 2010-22039 | 0 | 0 | 0900006480b444ef | ||
| FDA-2010-N-0002-0058 | FDA | None FDA-2010-N-0002 | Oral Dosage Form New Animal Drugs: Praziquantel and Pyrantel | Rule | NFR-Notice of Final Rule | 2010-09-03T04:00:00Z | 2010 | 9 | 2010-09-03T04:00:00Z | 2010-09-03T15:07:38Z | 2010-22043 | 0 | 0 | 0900006480b449d4 | |
| FDA-2010-N-0002-0051 | FDA | None FDA-2010-N-0002 | New Animal Drugs; Changes of Sponsors; Withdrawals of Approvals of New Animal Drug Applications: Deslorelin Acetate; Dichlorophene and Toluene Capsules; Pyrantel Pamoate Suspension | Rule | CEP-Certificate Extending Patent Term | 2010-08-27T04:00:00Z | 2010 | 8 | 2010-08-27T04:00:00Z | 2010-08-27T13:34:20Z | 2010-21296 | 0 | 0 | 0900006480b3c459 | |
| FDA-2010-N-0002-0050 | FDA | None FDA-2010-N-0002 | Withdrawals of Approvals of New Animal Drug Applications: Dichlorophene and Toluene Capsules | Notice | NWL-Notice of Withdrawl | 2010-08-27T04:00:00Z | 2010 | 8 | 2010-08-27T04:00:00Z | 2010-08-27T15:03:53Z | 2010-21295 | 0 | 0 | 0900006480b3c3b7 | |
| FDA-2010-N-0002-0048 | FDA | None FDA-2010-N-0002 | Implantations or Injectable Dosages Form New Animal Drugs: Propofol | Rule | NFR-Notice of Final Rule | 2010-07-06T04:00:00Z | 2010 | 7 | 2010-07-06T15:44:47Z | 2010-16301 | 0 | 0 | 0900006480b13970 | ||
| FDA-2010-N-0002-0049 | FDA | None FDA-2010-N-0002 | PROPOCLEAR (propofol) Injectable Cats and Dogs | Supporting & Related Material | SUP-Supplement (Supporting and Related Material) | 2010-07-06T04:00:00Z | 2010 | 7 | 2010-07-06T16:07:53Z | 0 | 0 | 0900006480b136d8 | |||
| FDA-2010-N-0002-0047 | FDA | None FDA-2010-N-0002 | Penicillin G Procaine Freedom of Information Summary NADA 065-010, Spnsored by Norbrook Laboratories, Ltd. | Supporting & Related Material | N-Notice (Supporting and Related Material) | 2010-06-21T04:00:00Z | 2010 | 6 | 2010-10-29T01:10:46Z | 0 | 0 | 0900006480b071b4 | |||
| FDA-2010-N-0002-0046 | FDA | None FDA-2010-N-0002 | Approval of a Supplemental New Animal Drug Application: Penicillin G Procaine Suspension | Notice | N-Notice | 2010-06-21T04:00:00Z | 2010 | 6 | 2010-06-21T04:00:00Z | 2010-10-29T01:10:46Z | 2010-14865 | 0 | 0 | 0900006480b06f57 | |
| FDA-2010-N-0002-0045 | FDA | None FDA-2010-N-0002 | New Animal Drugs for Use in Animal Feeds: Florfenicol | Rule | NFR-Notice of Final Rule | 2010-06-17T04:00:00Z | 2010 | 6 | 2010-10-29T01:10:45Z | 2010-14611 | 0 | 0 | 0900006480b03b6f | ||
| FDA-2010-N-0002-0041 | FDA | None FDA-2010-N-0002 | Ophthalmic and Topical Dosage Form New Animal Drugs: Ivermectin Topical Solution | Rule | NFR-Notice of Final Rule | 2010-05-12T04:00:00Z | 2010 | 5 | 2010-05-12T04:00:00Z | 2010-05-12T13:53:44Z | 2010-11244 | 0 | 0 | 0900006480aebea3 | |
| FDA-2010-N-0002-0044 | FDA | None FDA-2010-N-0002 | Freedom of Information (FOI) Summary for Orbax Oral Suspension (orbifloxacin) NADA 141-305 Sponsored by Intervet, Inc. | Supporting & Related Material | FOIS-Freedom of Information Summary | 2010-05-12T04:00:00Z | 2010 | 5 | 2010-05-12T14:31:24Z | 0 | 0 | 0900006480aeb8a8 | |||
| FDA-2010-N-0002-0039 | FDA | None FDA-2010-N-0002 | Implantation or Injectable Dosage Form New Animal Drugs: Ivermectin | Rule | NFR-Notice of Final Rule | 2010-05-12T04:00:00Z | 2010 | 5 | 2010-05-12T04:00:00Z | 2010-05-12T13:37:48Z | 2010-11282 | 0 | 0 | 0900006480aebe42 | |
| FDA-2010-N-0002-0043 | FDA | None FDA-2010-N-0002 | Oral Dosages Form New Animal Drugs: Orbifloxacin Suspension | Rule | NFR-Notice of Final Rule | 2010-05-12T04:00:00Z | 2010 | 5 | 2010-05-12T04:00:00Z | 2010-05-12T14:14:28Z | 2010-11245 | 0 | 0 | 0900006480aebeee | |
| FDA-2010-N-0002-0042 | FDA | None FDA-2010-N-0002 | Freedom of Information (FOI) Summary for (Ivermectin) Privermectin ANADA 200-340 Sponsored by First Priority, Inc. | Supporting & Related Material | FOIS-Freedom of Information Summary | 2010-05-12T04:00:00Z | 2010 | 5 | 2010-05-12T14:33:59Z | 0 | 0 | 0900006480aeb859 | |||
| FDA-2010-N-0002-0040 | FDA | None FDA-2010-N-0002 | Freedom of Information (FOI) Summary for Ivermectin Injection ANADA 200-429 Sponsored by Sparhawk Laboratories, Inc. | Supporting & Related Material | FOIS-Freedom of Information Summary | 2010-05-12T04:00:00Z | 2010 | 5 | 2010-05-12T13:46:42Z | 0 | 0 | 0900006480aeb854 | |||
| FDA-2010-N-0002-0038 | FDA | None FDA-2010-N-0002 | Animal Drugs, Feeds, and Related Products: Withdrawal of Approval of a New Animal Drug Application; Buquinolate; Coumaphos | Rule | NFR-Notice of Final Rule | 2010-05-05T04:00:00Z | 2010 | 5 | 2010-05-05T04:00:00Z | 2010-05-05T18:21:18Z | 2010-10564 | 0 | 0 | 0900006480ae7219 | |
| FDA-2010-N-0002-0037 | FDA | None FDA-2010-N-0002 | Withdrawal of Approval of New Animal Drug Applications: Coumaphos; Novobiocin; Buquinolate and Lincomycin | Notice | NWL-Notice of Withdrawl | 2010-05-05T04:00:00Z | 2010 | 5 | 2010-05-05T04:00:00Z | 2012-09-13T19:32:02Z | 2010-10567 | 0 | 0 | 0900006480ae714e | |
| FDA-2010-N-0002-0036 | FDA | None FDA-2010-N-0002 | Freedom Of Information (FOI) Summary - ANADA 200-446 Butorphine Veterinary Injection (Butorphanol tartrate, USP) Injectable Solution | Supporting & Related Material | FOIS-Freedom of Information Summary | 2010-04-29T04:00:00Z | 2010 | 4 | 2010-04-29T14:14:33Z | 0 | 0 | 0900006480ae353a | |||
| FDA-2010-N-0002-0035 | FDA | None FDA-2010-N-0002 | Implantation or Injectable Dosage Form New Animal Drugs: Butorphanol | Rule | NFR-Notice of Final Rule | 2010-04-29T04:00:00Z | 2010 | 4 | 2010-04-29T14:05:53Z | 2010-09871 | 0 | 0 | 0900006480ae39a6 | ||
| FDA-2010-N-0002-0034 | FDA | None FDA-2010-N-0002 | Norocillin Penicillin G Procaine Injectable Suspension (NADA 065-010) - Freedom of Information Summary | Other | FOIS-Freedom of Information Summary (No Federal Register Publication) | 2010-04-27T04:00:00Z | 2010 | 4 | 2010-04-27T19:56:00Z | 0 | 0 | 0900006480ae16d2 | |||
| FDA-2010-N-0002-0033 | FDA | None FDA-2010-N-0002 | Freedom Of Information Summary - [NADA 141-306 - Dormosed Gel Detomidine hydrochloride Oromucosal Gel Horses - Orion Corporation] | Supporting & Related Material | FOIS-Freedom of Information Summary | 2010-04-23T04:00:00Z | 2010 | 4 | 2010-04-23T15:17:21Z | 0 | 0 | 0900006480ade217 | |||
| FDA-2010-N-0002-0032 | FDA | None FDA-2010-N-0002 | Certain Other Dosage Form New Animal Drugs; Detomidine | Rule | NFR-Notice of Final Rule | 2010-04-23T04:00:00Z | 2010 | 4 | 2010-04-23T15:05:24Z | 2010-09371 | 0 | 0 | 0900006480ade6c3 | ||
| FDA-2010-N-0002-0031 | FDA | None FDA-2010-N-0002 | Freedom Of Information (FOI) Summary - Heifiermax 500, Optaflexx and Rumensin | Supporting & Related Material | FOIS-Freedom of Information Summary | 2010-04-22T04:00:00Z | 2010 | 4 | 2010-04-22T15:25:24Z | 0 | 0 | 0900006480add4cd | |||
| FDA-2010-N-0002-0030 | FDA | None FDA-2010-N-0002 | New Animal Drugs for Use in Animal Feeds: Melengestrol, Monensin, and Ractopamine | Rule | NFR-Notice of Final Rule | 2010-04-22T04:00:00Z | 2010 | 4 | 2010-04-22T13:40:34Z | 2010-09304 | 0 | 0 | 0900006480adcfba | ||
| FDA-2010-N-0002-0028 | FDA | None FDA-2010-N-0002 | New Animal Drugs: Change of Sponsor | Rule | NFR-Notice of Final Rule | 2010-04-20T04:00:00Z | 2010 | 4 | 2010-04-20T04:00:00Z | 2024-11-12T04:53:46Z | 2010-09057 | 1 | 0 | 0900006480adba4f | |
| FDA-2010-N-0002-0029 | FDA | None FDA-2010-N-0002 | New Animal Drugs: Change of Sponsor | Rule | NFR-Notice of Final Rule | 2010-04-20T04:00:00Z | 2010 | 4 | 2010-04-20T04:00:00Z | 2024-11-12T04:53:58Z | 2010-09045 | 1 | 0 | 0900006480adbad7 | |
| FDA-2010-N-0002-0027 | FDA | None FDA-2010-N-0002 | Implantation or Injectable Dosage Form New Animal Drugs: Change of Sponsor; Propofol | Rule | NFR-Notice of Final Rule | 2010-04-19T04:00:00Z | 2010 | 4 | 2010-04-19T04:00:00Z | 2024-11-07T22:17:54Z | 2010-08945 | 1 | 0 | 0900006480adaf52 | |
| FDA-2010-N-0002-0026 | FDA | None FDA-2010-N-0002 | Freedom Of Information Summary [NADA 141-266] - POSATEX Otic Suspension Orbifloxcin, Mometasone Furate Monohydrate and Posaconazole, Suspenion Dogs | Supporting & Related Material | BKG-Background Material | 2010-04-01T04:00:00Z | 2010 | 4 | 2010-04-01T16:12:53Z | 0 | 0 | 0900006480acde2d | |||
| FDA-2010-N-0002-0025 | FDA | None FDA-2010-N-0002 | Ophthalmic and Topical Dosage Form New Animal Drugs: Orbifloxacin, Mometasone Furoate Monohydrate, and Posaconazole Suspension | Rule | NFR-Notice of Final Rule | 2010-04-01T04:00:00Z | 2010 | 4 | 2010-04-01T16:05:18Z | 2010-07163 | 0 | 0 | 0900006480ace19b | ||
| FDA-2010-N-0002-0023 | FDA | None FDA-2010-N-0002 | Implantation or Injectable Dosage Form New Animal Drugs: Flunixin | Rule | NFR-Notice of Final Rule | 2010-03-19T04:00:00Z | 2010 | 3 | 2010-03-19T14:36:48Z | 2010-06038 | 0 | 0 | 0900006480ac18f4 | ||
| FDA-2010-N-0002-0024 | FDA | None FDA-2010-N-0002 | Freedom Of Information Summary - [ANADA 200-489] - FLUNAZINE-S (flunixin meglumine) Injectable Solution | Supporting & Related Material | FOIS-Freedom of Information Summary | 2010-03-19T04:00:00Z | 2010 | 3 | 2010-03-19T14:44:01Z | 0 | 0 | 0900006480ac19f7 | |||
| FDA-2010-N-0002-0022 | FDA | None FDA-2010-N-0002 | Oral Dosage Form New Animal Drugs: Tetracycline Powder; Technical Amendment | Rule | NFR-Notice of Final Rule | 2010-03-18T04:00:00Z | 2010 | 3 | 2010-03-18T04:00:00Z | 2010-03-18T15:23:20Z | 2010-05925 | 0 | 0 | 0900006480ac0362 | |
| FDA-2010-N-0002-0020 | FDA | None FDA-2010-N-0002 | New Animal Drugs for Use in Animal Feeds: Zilpaterol | Notice | NFR-Notice of Final Rule | 2010-03-11T05:00:00Z | 2010 | 3 | 2010-03-11T05:00:00Z | 2010-03-11T17:47:38Z | 0 | 0 | 0900006480abb716 | ||
| FDA-2010-N-0002-0021 | FDA | None FDA-2010-N-0002 | Freedom Of Information Summary - [ANADA 200-479] - HAEIFERMAX 500 plus Zilmax (melengestrol acetate and zilpaterol hydrochride) | Supporting & Related Material | FOIS-Freedom of Information Summary | 2010-03-11T05:00:00Z | 2010 | 3 | 2010-03-11T18:09:07Z | 0 | 0 | 0900006480abb71d | |||
| FDA-2010-N-0002-0018 | FDA | None FDA-2010-N-0002 | New Animal Drugs for Use in Animal Feeds: Zilpaterol | Notice | NFR-Notice of Final Rule | 2010-03-11T05:00:00Z | 2010 | 3 | 2010-03-11T05:00:00Z | 2010-03-11T15:56:32Z | 0 | 0 | 0900006480abb59e | ||
| FDA-2010-N-0002-0019 | FDA | None FDA-2010-N-0002 | Freedom Of Information Summary - [ANADA 200-480] - HAEIFERMAX 500 plus Zilmax (melengestrol acetate and zilpaterol hydrochride) | Supporting & Related Material | FOIS-Freedom of Information Summary | 2010-03-11T05:00:00Z | 2010 | 3 | 2010-03-11T17:30:03Z | 0 | 0 | 0900006480abb5a0 | |||
| FDA-2010-N-0002-0016 | FDA | None FDA-2010-N-0002 | New Animal Drugs for Use in Animal Feeds: Zilpaterol | Rule | NFR-Notice of Final Rule | 2010-03-11T05:00:00Z | 2010 | 3 | 2010-03-11T15:33:43Z | 2010-05224 | 0 | 0 | 0900006480abaf98 | ||
| FDA-2010-N-0002-0017 | FDA | None FDA-2010-N-0002 | Freedom Of Information Summary - [ANADA 200-483] - HAEIFERMAX 500 plus Zilmax (melengestrol acetate and zilpaterol hydrochride) | Supporting & Related Material | BKG-Background Material | 2010-03-11T05:00:00Z | 2010 | 3 | 2010-03-11T15:49:58Z | 0 | 0 | 0900006480abb097 | |||
| FDA-2010-N-0002-0014 | FDA | None FDA-2010-N-0002 | New Animal Drugs: Change of Sponsor | Rule | NFR-Notice of Final Rule | 2010-03-05T05:00:00Z | 2010 | 3 | 2010-03-09T14:28:56Z | 2010-04560 | 0 | 0 | 0900006480ab5f5b | ||
| FDA-2010-N-0002-0015 | FDA | None FDA-2010-N-0002 | Freedom of Information Summary Supplement New Animal Drug Application - [NADA 141-251 - Advantage Muti for Dogs - Bayer HealthCare LLC] | Supporting & Related Material | FOIS-Freedom of Information Summary | 2010-03-05T05:00:00Z | 2010 | 3 | 2010-03-05T19:55:18Z | 0 | 0 | 0900006480aaf84e | |||
| FDA-2010-N-0002-0012 | FDA | None FDA-2010-N-0002 | Freedom of Information Summary Supplement New Animal Drug Application for Tilmicosin - [NADA 149-929 - Elanco Animal Health] | Supporting & Related Material | BKG-Background Material | 2010-03-02T05:00:00Z | 2010 | 3 | 2010-03-03T20:30:11Z | 0 | 0 | 0900006480ab214b | |||
| FDA-2010-N-0002-0013 | FDA | None FDA-2010-N-0002 | New Animal Drugs for Use in Animal Feeds; Chlortetracycline | Notice | NFR-Notice of Final Rule | 2010-03-02T05:00:00Z | 2010 | 3 | 2010-03-02T17:55:52Z | 2010-04205 | 0 | 0 | 0900006480ab1f1b | ||
| FDA-2010-N-0002-0011 | FDA | None FDA-2010-N-0002 | Implantation or Injectable Dosage Form New Animal Drugs; Tilmicosin | Notice | NFR-Notice of Final Rule | 2010-03-02T05:00:00Z | 2010 | 3 | 2010-03-02T17:35:31Z | 2010-04206 | 0 | 0 | 0900006480ab1ea5 | ||
| FDA-2010-N-0002-0010 | FDA | None FDA-2010-N-0002 | Bacitracin Zinc and Nicarbazin, ANADA 200-478, Albac 50 plus Nicarb; Freedom of Information (FOI) Summary | Supporting & Related Material | FOIS-Freedom of Information Summary | 2010-02-23T05:00:00Z | 2010 | 2 | 2010-02-23T14:39:57Z | 0 | 0 | 0900006480aab373 | |||
| FDA-2010-N-0002-0009 | FDA | None FDA-2010-N-0002 | New Animal Drugs for Use in Animal Feeds: Bacitracin Zinc; Nicarbazin | Rule | NFR-Notice of Final Rule | 2010-02-22T05:00:00Z | 2010 | 2 | 2010-02-22T05:00:00Z | 2010-02-23T13:57:08Z | 2010-03328 | 0 | 0 | 0900006480aa9b3b | |
| FDA-2010-N-0002-0008 | FDA | None FDA-2010-N-0002 | Freedom of Information Summary - [141-301]- Ractopamine Hydrochloride and Monensin, USP Type A Medicated Arcticles to be used in the Manufacture of Type C Medicated Feeds Finishing Hen and Tom Turkeys | Supporting & Related Material | FOIS-Freedom of Information Summary | 2010-02-16T05:00:00Z | 2010 | 2 | 2010-02-17T17:02:48Z | 0 | 0 | 0900006480aa5817 | |||
| FDA-2010-N-0002-0007 | FDA | None FDA-2010-N-0002 | New Animal Drugs for Use in Animal Feeds: Ractopamine; Monensin | Notice | NFR-Notice of Final Rule | 2010-02-05T05:00:00Z | 2010 | 2 | 2010-02-05T05:00:00Z | 2010-02-17T05:05:20Z | 2010-02427 | 0 | 0 | 0900006480a8e9ae | |
| FDA-2010-N-0002-0006 | FDA | None FDA-2010-N-0002 | Labeling of EXCEDE - [ NADA 141-209 - Freedom of Information ] | Supporting & Related Material | Freedom of Information Summary | 2010-02-03T05:00:00Z | 2010 | 2 | 2014-01-07T21:32:50Z | 0 | 0 | 0900006480a8bb21 | |||
| FDA-2010-N-0002-0005 | FDA | None FDA-2010-N-0002 | Labeling - [ NADA 141-298 - Freedom of Information ]; Surolan | Supporting & Related Material | Freedom of Information Summary | 2010-02-03T05:00:00Z | 2010 | 2 | 2014-01-07T21:29:16Z | 0 | 0 | 0900006480a8bb1f | |||
| FDA-2010-N-0002-0003 | FDA | None FDA-2010-N-0002 | Ophthalmic and Topical Dosage Form New Animal Drugs; Miconazole, Polymixin B, and Prednisolone Suspension | Notice | Notice of Final Rule | 2010-01-29T05:00:00Z | 2010 | 1 | 2010-01-29T05:00:00Z | 2013-07-08T19:24:29Z | 2010-01794 | 0 | 0 | 0900006480a870c7 | |
| FDA-2010-N-0002-0002 | FDA | None FDA-2010-N-0002 | EXCEDE Sterile Suspension, Ceftiofur Crystalline Free Acid Horses - Freedom of Information Summary - [NADA-141-209] | Supporting & Related Material | Freedom of Information Summary | 2010-01-29T05:00:00Z | 2010 | 1 | 2014-01-07T21:31:43Z | 0 | 0 | 0900006480a86f5c | |||
| FDA-2010-N-0002-0001 | FDA | None FDA-2010-N-0002 | Implantation or Injectable Dosage Form New Animal Drugs; Ceftiofur Crystalline Free Acid | Notice | Notice of Final Rule | 2010-01-29T05:00:00Z | 2010 | 1 | 2010-01-29T05:00:00Z | 2013-07-08T19:48:56Z | 2010-01790 | 0 | 0 | 0900006480a87061 | |
| FDA-2010-N-0002-0004 | FDA | None FDA-2010-N-0002 | Freedom of Information Summary - [NADA-141-298] | Supporting & Related Material | Freedom of Information Summary | 2010-01-29T05:00:00Z | 2010 | 1 | 2013-07-08T19:26:42Z | 0 | 0 | 0900006480a86f5e |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;